Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 6090539)

Published in J Infect Dis on September 01, 1984

Authors

R J Whitley, M Levin, N Barton, B J Hershey, G Davis, R E Keeney, J Whelchel, A G Diethelm, P Kartus, S J Soong

Articles citing this

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev (2003) 1.95

Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J Virol (1997) 1.44

Screening for antiviral activities of isolated compounds from essential oils. Evid Based Complement Alternat Med (2011) 1.18

Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother (2002) 1.10

Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother (1986) 1.09

Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother (1987) 1.08

Topical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisal. Can Fam Physician (1991) 1.08

Herpes simplex keratitis in renal transplant patients. Br J Ophthalmol (1991) 1.07

Mixed viral infections: detection and management. Clin Microbiol Rev (1994) 1.05

Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96

Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol (2005) 0.93

Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood. Antimicrob Agents Chemother (2007) 0.90

Herpes latency, meningitis, radiculomyelopathy and disseminated infection. Genitourin Med (1994) 0.87

Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro. Iran J Microbiol (2014) 0.79

Articles by these authors

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68

The major human rhinovirus receptor is ICAM-1. Cell (1989) 7.81

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science (1990) 6.70

Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet (1999) 6.02

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36

Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1995) 5.13

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02

Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51

Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28

Racial equity in renal transplantation. The disparate impact of HLA-based allocation. JAMA (1993) 4.26

Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet (1990) 4.12

Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med (2001) 4.10

Morbidity and severity of illness during interhospital transfer: impact of a specialised paediatric retrieval team. BMJ (1995) 4.05

The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest (1972) 3.96

Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child (2001) 3.94

Emergency management of meningococcal disease. Arch Dis Child (1999) 3.93

A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80

A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med (1991) 3.78

The natural history of herpes simplex virus infection of mother and newborn. Pediatrics (1980) 3.65

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest (1997) 3.52

Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J Exp Med (1973) 3.22

A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med (1993) 2.98

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94

Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ (1997) 2.93

Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91

Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76

The barrier to genetic exchange between hybridising populations. Heredity (Edinb) (1986) 2.72

Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics (1980) 2.70

Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis (1982) 2.70

Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development. Neuron (2000) 2.70

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65

Unsuspected HIV infection presenting in first year of life. BMJ (1995) 2.62

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA (1999) 2.56

Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56

Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet (1988) 2.54

NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med (1978) 2.52

Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A (1987) 2.48

Isolation and characterization of cDNA clones for human skeletal muscle alpha actin. Nucleic Acids Res (1983) 2.45

Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41

Multiple tracer dilution estimates of D- and 2-deoxy-D-glucose uptake by the heart. Am J Physiol (1986) 2.39

Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38

Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37

A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock. Crit Care Med (2000) 2.35

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation (1991) 2.32

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30

Management of Kawasaki disease. Arch Dis Child (2013) 2.30

Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19

Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. QJM (2003) 2.18

Acute inflammation of the temporomandibular joint presenting as classical trigeminal neuralgia--case report and hypothesis. Headache (1988) 2.16

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res (1990) 2.16

Gamma oscillations and object processing in the infant brain. Science (2000) 2.14

Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child (2002) 2.11

A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09

Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med (1976) 2.09

A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09

Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med (1992) 2.07

Renal transplantation in children with posterior urethral valves. J Urol (1991) 2.06

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06

Estimates of selection and gene flow from measures of cline width and linkage disequilibrium in heliconius hybrid zones. Genetics (1990) 2.05

SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils. J Biol Chem (1994) 2.04

Association of intraoperative blood pressure instability with adverse outcomes after liver transplantation. Minerva Anestesiol (2013) 2.03

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A (2000) 1.99

Sensitivity analysis in optimization of time-distributed parameters for a coronary circulation model. Med Prog Technol (1980) 1.98

RS-61443--a phase I clinical trial and pilot rescue study. Transplantation (1992) 1.97

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis (1991) 1.94

Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr (1992) 1.94

The course of severe chronic fatigue syndrome in childhood. J R Soc Med (2000) 1.93

Psychiatric adjustment in adolescents with a history of chronic fatigue syndrome. J Am Acad Child Adolesc Psychiatry (1999) 1.91

Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90

Potentially lethal bacterial infection associated with varicella zoster virus. BMJ (1996) 1.88

Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta (1977) 1.84

Herpes simplex encephalitis. Clinical Assessment. JAMA (1982) 1.83

The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct (2001) 1.82

The N-ethylmaleimide-sensitive fusion protein and alpha-SNAP induce a conformational change in syntaxin. J Biol Chem (1995) 1.81

Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease? Arch Intern Med (1998) 1.80

Does computed tomography have a role in the evaluation of complicated acute bacterial meningitis in childhood? Dev Med Child Neurol (1992) 1.79

Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76

Ferrocene-mediated enzyme electrode for amperometric determination of glucose. Anal Chem (1984) 1.75

ON THE EXACERBATION IN CHRONIC GLOMERULONEPHRITIS. J Clin Invest (1940) 1.70

Can we manage sport related concussion in children the same as in adults? Br J Sports Med (2004) 1.69

A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med (1990) 1.67

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med (1982) 1.67

The prognostic significance of ulceration of cutaneous melanoma. Cancer (1980) 1.66

Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1996) 1.66

Avoidable deficiencies in the delivery of health care to children with meningococcal disease. J Accid Emerg Med (1998) 1.65

Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis (1996) 1.64

DIET AS A PROPHYLACTIC AGENT AGAINST PUERPERAL SEPSIS. Br Med J (1931) 1.64